E. Antonio Chiocca

Brigham and Women's Hospital — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

86h-index25.7kcitations634works2.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(178), Glioma Diagnosis and Treatment(149), CAR-T cell therapy research(109), Cancer Immunotherapy and Biomarkers(84), Renal Transplantation Outcomes and Treatments(60)

Publications630 total

Table S7 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
2025Open Access
Table S6 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
2025Open Access
Supplementary Fig. 6 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
2025Open Access
Supplementary Fig. 4 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
2025Open Access
Table S5 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
2025Open Access
Supplementary Fig. 3 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
2025Open Access
Table S4 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
2025Open Access
Supplementary Fig. 2 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
2025Open Access
Table S3 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
2025Open Access
Supplementary Fig. 5 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
2025Open Access
Table S8 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
2025Open Access
Table S1 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
2025Open Access
Table S2 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
2025Open Access
Supplementary Fig. 1 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
2025Open Access
INNV-33. Investigative needle core biopsies support multimodal deep-data generation in glioblastoma
Neuro-Oncology·2025
TMIC-30. Tumor-specific response to armed-oncolytic herpesvirus targeting cDC1 DC-CD8 T cell axis in glioblastoma mouse models
Neuro-Oncology·2025Open Access
EXTH-102. Targeting Glioblastoma Immune Evasion with HSV-1 Vectors to Enhance Antigenicity
Neuro-Oncology·2025Open Access
Serial multiomics uncovers anti-glioblastoma responses not evident by routine clinical analyses
Science Translational Medicine·2025· 7 cited
Treatment strategies for leptomeningeal disease in patients with breast cancer
Pharmacology & Therapeutics·2025
Departments of Neurosurgery are Leaders in Highly Cited Glioblastoma Research
Neurosurgery Open·2025Open Access
page 1 of 32Next →

Frequent Co-authors

Sean Lawler(15), David A. Reardon(9), Jakub Godlewski(8), Ralph Weissleder(8), Balveen Kaur(8), Michal O. Nowicki(7), Fred H. Hochberg(7), Keith L. Ligon(6), Patrick Y. Wen(5), Agnieszka Bronisz(5), Jianhua Yu(5), Yoshinaga Saeki(5), Herbert B. Newton(4), Maria C. Speranza(4), Hiroshi Nakashima(4), Xandra O. Breakefield(4), Gordon J. Freeman(4), David N. Louis(4), Giulia Fulci(4), Michael A. Caligiuri(4)